Uxin (UXIN) Cash & Equivalents (2016 - 2026)

Uxin (UXIN) has 11 years of Cash & Equivalents data on file, last reported at $6.9 million in Q1 2026.

• Quarterly Cash & Equivalents fell 51.8% year-over-year to $6.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.9 million (down 51.8% YoY) and the FY2025 annual result came in at $11.9 million, up 245.06% from the prior year.
• Cash & Equivalents eased to $6.9 million in Q1 2026, from $11.7 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $2.4 billion in Q3 2023 to a low of $3424.0 in Q3 2022.
• A 5-year average of $149.6 million and a median of $4.1 million in 2024 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents slumped 99.99% — and 2023, when it jumped 71183495.21%.
• Tracing UXIN's Cash & Equivalents over 5 years: stood at $15088.0 in 2022, then surged by 17711.98% to $2.7 million in 2023, then soared by 30.08% to $3.5 million in 2024, then jumped by 234.76% to $11.7 million in 2025, then tumbled by 41.33% to $6.9 million in 2026.
• The last three Cash & Equivalents figures came in at $6.9 million (Q1 2026), $11.7 million (Q4 2025), and $10641.5 (Q3 2025), per Business Quant data.